Oncomedics
 |
||
Oncomedics is a biotechnology company specialising in the personalisation of cancer treatments. We are developing in vitro diagnostic medical devices that provide decision support to practitioners (surgeons, pathologists and oncologists) in order to identify the most effective treatments to cure a patient.
Founded in 2006 by Christophe Lautrette and Stéphanie Giraud, Oncomedics has its own laboratory and production unit in Limoges (Nouvelle-Aquitaine, France). Oncomedics has established numerous solid collaborations with clinical centres (AP-HP, HCL, Institut Bergonié), academic laboratories (Paris, Lyon, Marseille), pharmaceutical industries (Ipsen, Sanofi... ) and biotechnology companies (Oncodesign). | ||
OncoMiD-Diss® culture media for primary tumor cells
The OncoMiD-Diss® dissociation media series is specifically optimised for dissociating human tumour samples. It allows the dissociation of tumour samples into individual cells, thus facilitating their entry into primary culture. Four tubes containing different products are required to initiate, control and stop tumour dissociation, combined with specific procedures for each cell type. The specific OncoMiD-Diss® Kit have been developed for the dissociation of tumours from:
-
Breast tumours
 |
Cat# | Description | Cond. |
| OMDISS2-Breast | OncoMid-Diss Breast Cancer Tissue Dissociation Kit | Kit |
-
Colon/rectum tumours
 |
Cat# | Description | Cond. |
| OMDISS2 | OncoMid-Diss Colorectal Cancer Tissue Dissociation Kit | Kit |
-
Ovarian tumours
 |
Cat# | Description | Cond. |
| OMDISS2-Ovary | OncoMid-Diss Ovary Cancer Tissue Dissociation Kit | Kit |
Storage : 2-8°C
For Reasearch Use Only
For profit organization / Corporations, please contact tech@clinisciences.com for quotation
Resultados de su búsqueda : 3 Producto encontrado
Refine su búsqueda :
- primary 2
- Primary cells 2
- kit 1